Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heroin-associated nephropathy. A nationwide problem.

E E Cunningham, M A Zielezny, R C Venuto

    JAMA
    |December 2, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Postpartum hemolytic uremic syndrome in a patient with preexisting hypertension and resolving preeclampsia.

    Clinical nephrology·2007
    Same author

    Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.

    Clinical transplantation·2005
    Same author

    Bacterial toxins and enteral feeding of premature infants at risk for necrotizing enterocolitis.

    Advances in experimental medicine and biology·2002
    Same author

    Thromboxane receptors in human kidney tissues.

    Prostaglandins & other lipid mediators·1999
    Same author

    Hemodynamic and renal effects of U-46619, a TXA2/PGH2 analog, in late-pregnant rats.

    The American journal of physiology·1999
    Same author

    CD4+ and CD8+ lymphocyte and cortisol response patterns in elderly and young males after methylprednisolone exposure.

    Journal of medicine·1998

    Heroin-associated nephropathy (HAN) significantly impacts young adults, particularly Black men, leading to end-stage renal disease (ESRD). This study highlights the potential nationwide prevalence and economic burden of HAN on the healthcare system.

    Area of Science:

    • Nephrology
    • Public Health
    • Addiction Medicine

    Background:

    • Heroin-associated nephropathy (HAN) is a recognized cause of end-stage renal disease (ESRD) in specific demographics.
    • Previous data on the national scope and impact of HAN has been limited.

    Purpose of the Study:

    • To assess the national importance and prevalence of heroin-associated nephropathy (HAN).
    • To understand the demographic characteristics of patients with HAN.
    • To estimate the economic impact of treating HAN.

    Main Methods:

    • A questionnaire was distributed to 130 dialysis units across the United States.
    • Data on HAN cases, patient demographics, and disease stage were collected from responding centers.
    • Economic impact was estimated based on the cost of dialysis for affected patients.

    Related Experiment Videos

    Main Results:

    • Twenty-three responses from 14 metropolitan areas reported 98 cases of HAN.
    • The majority of patients (93.9%) were Black, with Black men constituting the largest demographic group (78.6%).
    • End-stage renal disease (ESRD) was already present in 67.3% of HAN patients.

    Conclusions:

    • Heroin-associated nephropathy (HAN) is a significant cause of ESRD, disproportionately affecting the Black population.
    • The findings suggest a substantial national burden of HAN, with considerable economic implications for dialysis treatment.
    • Further research is needed to determine the true national prevalence and develop targeted interventions.